Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) TAI

Currency In TWD

AD

Valuation

Market Cap1.36B
Enterprise Value1.95B
P/E Ratio-39.03
PEG Ratio0.28
Price/Sales Ratio2.99
Price/Book Ratio0.63
Enterprise/Revenue3.44
Enterprise/EBITDA21.3

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.06
Operating Margin-0.15
AD

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.02

Income Statement

Revenue804.88M
Revenue/Share16.94
Gross Profit-8.86M
EBITDA-47.6M
Net Income-243.85M
Diluted EPS-4.39

Balance Sheet

Total Cash329.96M
Total Cash/Share5.98
Total Debt755.63M
Total Debt/Equity0.24
Current Ratio4.06
Book Value Per Share58.07

Price History

52-Week Change31.76
52-Week High44.75
52-Week Low24.2
Moving Average 50 Days35.69
Moving Average 200 Days30.44

Statistics

Average Volume458,890
Shares Outstanding76.92M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.19
Trailing Annual Dividend Yield0.53
Payout Ratio-0.29
Last Split FactorN/A
Last Split DateN/A
AD